UGC Approved Journal no 63975(19)
New UGC Peer-Reviewed Rules

ISSN: 2349-5162 | ESTD Year : 2014
Volume 12 | Issue 10 | October 2025

JETIREXPLORE- Search Thousands of research papers



WhatsApp Contact
Click Here

Published in:

Volume 12 Issue 3
March-2025
eISSN: 2349-5162

UGC and ISSN approved 7.95 impact factor UGC Approved Journal no 63975

7.95 impact factor calculated by Google scholar

Unique Identifier

Published Paper ID:
JETIR2503564


Registration ID:
557491

Page Number

f273-f293

Share This Article


Jetir RMS

Title

NOVEL APRROACHES IN DRUG DESIGN & DEVELOPMENT

Abstract

An essential component of research into finding and maximizing substances for medicinal application is drug design & development. The goal of this technique is to find compounds that may selectively and effectively interact with biological targets by integrating principles from a variety of fields, such as chemistry, biology, pharmacology, and computer science. Technological developments, especially in computational biology and techniques, have completely changed the drug discovery process by making it possible to rationally design compounds with improved safety and efficacy profiles. An outline of the main phases of drug development is given in this abstract, including target validation and identification, lead optimization, and preclinical research. The significance of comprehending target structures and mechanisms is emphasized, along with the use of cutting-edge methods including virtual screening, molecular modeling, and structure-activity relationship (SAR) research. In addition, ways to deal with problems including medication resistance, pharmacokinetic variability, and toxicity evaluation are covered. Delivering safe and effective treatments that answer unmet medical needs is the ultimate goal of drug design, highlighting the multidisciplinary nature and constantly changing approaches in this dynamic discipline.

Key Words

Novel drug design, AI-driven discovery, Computational modeling, Targeted therapy, Machine learning, Molecular docking, QSAR, Personalized medicine, Drug repurposing, CRISPR, Pharmacogenomics

Cite This Article

"NOVEL APRROACHES IN DRUG DESIGN & DEVELOPMENT", International Journal of Emerging Technologies and Innovative Research (www.jetir.org), ISSN:2349-5162, Vol.12, Issue 3, page no.f273-f293, March-2025, Available :http://www.jetir.org/papers/JETIR2503564.pdf

ISSN


2349-5162 | Impact Factor 7.95 Calculate by Google Scholar

An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 7.95 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator

Cite This Article

"NOVEL APRROACHES IN DRUG DESIGN & DEVELOPMENT", International Journal of Emerging Technologies and Innovative Research (www.jetir.org | UGC and issn Approved), ISSN:2349-5162, Vol.12, Issue 3, page no. ppf273-f293, March-2025, Available at : http://www.jetir.org/papers/JETIR2503564.pdf

Publication Details

Published Paper ID: JETIR2503564
Registration ID: 557491
Published In: Volume 12 | Issue 3 | Year March-2025
DOI (Digital Object Identifier):
Page No: f273-f293
Country: -, -, India .
Area: Engineering
ISSN Number: 2349-5162
Publisher: IJ Publication


Preview This Article


Downlaod

Click here for Article Preview

Download PDF

Downloads

00060

Print This Page

Current Call For Paper

Jetir RMS